ASA Biopharm's Podcast

Jan 16 2025 111 ep. 40 mins 306
ASA Biopharm's Podcast artwork

In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.

RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Episode 111: Nan Laird

Jan 16 2025 49 mins  
A look at the life and accomplishments of Nan Laird.

Episode 110: STATBOLIC Cardiometabolic Statistical Workshop

Dec 05 2024 27 mins  
Jürgen Hummel, Hiya Banerjee, Jingyi Liu, Jason Legg, and Henrik Ravn discuss the inaugural STATBOLIC Workshop.

Episode 109: Ian Sturdy

Jun 09 2024 33 mins  
Ian describes how to leverage ChatGPT to accelerate statistical programming in the medical product industry.Related paper available here: https://www.pharmasug.org/proceedings/2024/AP/PharmaSUG-2024-AP-256.pdf

Episode 108: Working Moms

May 06 2024 37 mins  
Elaine Hoffman, Rebbecca Wilson, Christina Nurse, and Amy LaLonde discuss the balancing act between family and career.

Episode 107: SPAIG Committee

Feb 09 2024 27 mins  
Scott Clark, Satrajit Roychoudhury, and Michelle Shardell discuss the Statistical Partnerships Among Academe, Industry & Government (SPAIG) Committee.https://community.amstat.org/spaig/home

Episode 106: Rebbecca Wilson

Jun 02 2023 40 mins  
Amy welcomes Rebbecca to the co-hosting chair while Christina enjoys some time off with her new baby (congrats)! The two discuss Rebbecca’s fascinating career thus far and how communication styles differ across male and female leaders.Reference: https://hbr.org/2022/12/research-men-speak-more-abstractly-than-women

Episode 105: Adrian Coles and Wendy Martinez

Apr 28 2023 43 mins  
Adrian and Wendy discuss imposter syndrome and being confident in your career.

Episode 104: Steve Ruberg

Jan 17 2023 61 mins  
In our first episode of the new year, we interview Steve Ruberg, an ASA fellow with over 35 years of experience in the biopharmaceutical industry and an active proponent of the Tripartite Estimand Approach.

Episode 103: Tian Gu

Sep 30 2022 28 mins  
Tian discusses her research in data integration methods and the bias arising from lack of representation.

Episode 102: LaShell Robinson

Aug 03 2022 36 mins  
LaShell discusses diversity, equity, and inclusion in clinical trials.